High-frequency therapy of primary axillary hyperhidrosis

The article is devoted to a new method of treatment ofprimary axillary hyperhidrosis UHF technology. Anatomy, topography and function of the sweat glands, as well as the mechanism of action of ultrahigh-frequency therapy electromagnetic field frequency from 30 to 300 MHz (wavelength of 10 m to 1 m) in continuous or pulsed mode are described. The aim of the study was to investigate the efficacy and safety of UHF-therapy apparatus SweatX at axillary hyperhidrosis. Inclusion criteria was hyperhidrosis corresponding to the scale of gravity HDSS (Hyperhidrosis Disease Severity Scale) 3 rd and 4 th degree: before treatment in 8 patients HDSS level was equal to 4, in 12 patients - 3. Each patient received a series 4 treatments with an interval of 1 week. Underarm pictures with iodine-starch test subjects was performed at baseline and after 1, 3 and 6 months after the last treatment. Each procedure SweatX exposure consisted of two stages. The total processing time of each axilla was 8-10 minutes (about 20 minutes on both armpits). In the study, as well as between the procedures and follow-up visits were observed no undesirable side effects. After 6 months of follow up indicators HDSS sweating on a scale from 11 (55%) patients dropped to 2, and 9 (45%) patients -1. Thus, on the basis of SweatX use of UHF technology provides a safe, effective and lasting solution to the problems encountered in patients with primary hyperhidrosis underarm.

primary axillary hyperhidrosis, noninvasive UHF technology